Weijun Gao

Title: Weijun Gao: Innovator in Pharmaceutical Chemistry

Introduction

Weijun Gao is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for drug quality control. His work is characterized by a focus on innovative solutions that enhance the efficacy and safety of pharmaceutical formulations.

Latest Patents

Weijun Gao holds a patent for a compound titled "Phenyl amino sodium propionate derivative, preparation method therefor and application thereof." This patent discloses a phenyl amino sodium propionate derivative, along with its preparation method and applications. Specifically, it details sodium 3-(4-(2-(9H-carbazole-9-yl)ethoxy)phenyl)-2-((2-(4-(4-(2-sodium forrnate-2-((2-(4-fluorobenzoyl)phenyl)amino)ethyl)phenoxy)benzoyl)phenyl)amino)propionate. This compound is particularly useful for quality control of the bulk drug or formulation of Chiglitazar or its derivatives. It can serve as a control or standard substance for detecting impurities and related substances in Chiglitazar or its sodium salt drugs.

Career Highlights

Weijun Gao is currently employed at Shenzhen Chipscreen Biosciences Co., Ltd. His role at the company allows him to apply his expertise in pharmaceutical chemistry to develop innovative solutions that address critical challenges in drug formulation and quality assurance. His contributions have been instrumental in advancing the company's research and development efforts.

Collaborations

Weijun Gao collaborates with several talented individuals in his field, including Xianghui Wang and Xingyu Deng. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Weijun Gao is a prominent inventor whose work in pharmaceutical chemistry has led to significant advancements in drug quality control. His innovative patent and collaborative efforts exemplify his commitment to improving pharmaceutical formulations. His contributions continue to impact the industry positively.